Author: jschoales
-
Patient Partner Learning & Education Grants
3CTN is excited to offer grant opportunities for Patient Partners across our Network to help cover the cost of participating in educational courses, meetings or conferences. These grants are intended to promote learning and development to enhance the impact of patient engagement in clinical trials across Canada. Individual requests of up to $1,500 will be…
-
Revised EDI Framework and Toolkit in Collaboration with Queering Cancer
The latest edition of our Equity, Diversity, and Inclusion (EDI) Framework and Toolkit is now available. In collaboration with Kim Meeking, Co-Lead for Queering Cancer, we have enriched the toolkit with additional resources and best practices aimed at addressing the unique needs of sexual and gender diverse (SGD) communities. This updated revision includes new resources…
-
impACCT Virtual Rounds Fall Session 2024
When: Tuesday, October 22, 2024 12:00 pm -1:00 pm EDT Trial #1: (CCTG) SC.29: A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases Speaker: Dr. Arjun Sahgal, MD, Chief of Radiation Oncology and the Radiation Treatment Program, Sunnybrook…
-
-
-
Patient Partner Learning Annex Informational Session
3CTN is excited to announce that we are holding an informational session on June 26, 2024 (1 – 2 pm EDT) for our recently launched Patient Partner Learning Annex tool.
-
impACCT Virtual Rounds Spring Session 2024
When: Thursday, May 23, 2024 12:00 pm -1:00 pm EDT Featured Trial (CHUQ) BicaBCa: A phase II randomized trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer (NCT05327647) Speaker: Dr. Paul Toren, MD, Associate Professor, Department of Surgery – Faculty of Medicine, Université Laval Speaker: Dr. Joe Pater, MD, Emeritus Professor,…
-
EDI Toolkit and Resources
We recently add a new page to our website! The Equity, Diversity and Inclusion (EDI) in Clinical Trials contains EDI resources developed by 3CTN and our recently completed EDI Toolkit.
-
-
A Tool for Patient Partner Development
Embedding Patient and Public Involvement (PPI) as a means for helping assure patient values and perspectives are reflected in clinical trials conduct has been a founding priority of the Canadian Cancer Clinical Trials Network (3CTN). Our community of Patient Representatives guide and support trial activities locally at cancer centres and centrally through participation in Network…